Menveo 1 vial-a-c-y-w-135-DIP 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FJ5K4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $347,163
Award facts
- Contract value 100% obligated
- $347,163.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerIsourgebergen Drug Corp, a subsidiary of Cencora, Inc., received a delivery order valued at $347,163.30 from the Defense Logistics Agency (DLA) on January 20, 2026, for the supply of Menveo 1 vial (A-C-Y-W-135-DIP) 0.5ML vaccine. The contract is firm fixed price with no set-aside designation, indicating competitive award based on capability. Performance will be fulfilled from the company's location in Conshohocken, Pennsylvania, with an ultimate completion date of January 21, 2026. This delivery order operates under Cencora's larger Indefinite Delivery Contract with DLA Troop Support Medical, a single-award vehicle valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary mechanism for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerIsourgebergen's pharmaceutical distribution capabilities position it as a critical federal vendor for the DLA's medical supply chain. The company maintains an extensive portfolio delivering brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains to military treatment facilities and other federal healthcare systems. The rapid completion timeline—with performance due the day after award—reflects the standard operational procedures for vaccine procurement under the established IDC framework, ensuring timely availability of immunological products for military medical readiness.
Quick answers
Who was awarded contract SPE2DR26FJ5K4?
SPE2DR26FJ5K4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FJ5K4 worth?
The government has obligated $347,163 on SPE2DR26FJ5K4.
Is contract SPE2DR26FJ5K4 an order under another contract?
Yes. SPE2DR26FJ5K4 is a delivery order under SPE2DR25D2009, an indefinite delivery contract.
Was contract SPE2DR26FJ5K4 competed?
The extent of competition for SPE2DR26FJ5K4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award